Revised Intrinsic Valuation Highlights Overvaluation

2 months ago

Parkev Tatevosian, CFA

"So, my intrinsic value per share I updated today for Palunteer stock increased by 40%. I previously had this business rated at $50 per share and I increased that today to $70 per share. Now, the stock is still overvalued in my opinion, trading at a market price of 194 compared to my intrinsic value calculation of 70, but the company's making great progress. And the reason why the intrinsic value per share increased is because the company's beta was significantly higher before."

The speaker details an updated intrinsic valuation for Palantir (PLTR), raising the per share value from $50 to $70 due to a downward adjustment of the company beta, reflecting reduced risk. Despite the progress and expanded enterprise focus, the market price at 194 remains significantly above the intrinsic estimate, underscoring an overvalued condition.

Related Stocks